BMO Capital Markets’ Evan Seigerman: I’m encouraged by Pfizer raising 2025 profit outlook

Evan David Seigerman, BMO Capital Markets managing director & healthcare head, joins CNBC’s ‘Squawk on the Street’ to discuss outlooks on Pfizer.